Atlas Trials

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

Clinical trial NCT00405171 · COMPLETED

Trial details

NCT number
NCT00405171
Sponsor
University Hospital, Caen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV InfectionsHypercholesterolemiaAntiretroviral Therapy
Start date
2003-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.